AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT of AROG PHARMACEUTICALS LLCLimited Liability Company Agreement • September 28th, 2018 • Arog Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 28th, 2018 Company Industry JurisdictionAMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT (this “Agreement”) OF AROG PHARMACEUTICALS LLC, a Delaware limited liability company (the “Company”), dated as of [●], 2018, by and among the Company, Arog Pharmaceuticals Holdings, Inc., a Delaware corporation (“Pubco”), and JI Biotech, Inc., a Delaware corporation (the “Continuing LLC Owner”).
LOAN AGREEMENTLoan Agreement • September 28th, 2018 • Arog Pharmaceuticals, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledSeptember 28th, 2018 Company Industry JurisdictionTHIS LOAN AGREEMENT (this “Loan Agreement”) dated effective as of September 8, 2017 (the “Effective Date”) is made and executed by and between Jain Investments, LLC, a Texas limited liability company (the “Lender”) and Arog Pharmaceuticals, Inc., a Delaware corporation (the “Borrower”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 28th, 2018 • Arog Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 28th, 2018 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) is made and entered into effective as of January 5, 2015 (the “Effective Date”), by and between Arog Pharmaceuticals, Inc., a Delaware corporation ( “Seller”), and Videra Pharmaceuticals, LLC a Delaware limited liability company ( “Buyer”). Seller and Buyer are sometimes referred to herein as the “Parties,” and each, a “Party.”
TAX RECEIVABLE AGREEMENT among AROG PHARMACEUTICALS HOLDINGS, INC. AROG PHARMACEUTICALS LLC and THE PERSONS NAMED HEREIN Dated as of [•], 2018Tax Receivable Agreement • September 28th, 2018 • Arog Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 28th, 2018 Company Industry JurisdictionThis TAX RECEIVABLE AGREEMENT (as amended from time to time, this “Agreement”), dated as of [•], 2018, is hereby entered into by and among Arog Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Corporate Taxpayer”), Arog Pharmaceuticals LLC, a Delaware limited liability company (“OpCo”), each of the Members (as defined below) from time to time party thereto, and each of the successors and assigns thereto.